Risk of incident diabetes post-COVID-19: A systematic review and meta-analysis

Sathish, 2021, Proportion of newly diagnosed diabetes in COVID ‐19 patients: a systematic review and meta‐analysis, Diabetes Obes. Metab., 23, 870, 10.1111/dom.14269 Khunti, 2021, COVID-19, hyperglycemia, and new-onset diabetes, Diabetes Care, 44, 2645, 10.2337/dc21-1318 Xie, 2022, Risks and burdens of incident diabetes in long COVID: a cohort study, Lancet Diabetes Endocrinol., 10.1016/S2213-8587(22)00044-4 Barrett, 2022, Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 Years — United States, March 1, 2020–June 28, 2021, MMWR Morb. Mortal. Wkly Rep., 71, 59, 10.15585/mmwr.mm7102e2 Daugherty, 2021, Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study, BMJ, n1098, 10.1136/bmj.n1098 Ayoubkhani, 2021, Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study, BMJ, n693, 10.1136/bmj.n693 Al-Aly, 2021, High-dimensional characterization of post-acute sequelae of COVID-19, Nature, 594, 259, 10.1038/s41586-021-03553-9 Rathmann, 2022, Incidence of newly diagnosed diabetes after Covid-19, Diabetologia, 10.1007/s00125-022-05670-0 Birabaharan, 2022, Risk of new‐onset type 2 diabetes in 600 055 people after COVID ‐19: A cohort study, Diabetes Obes. Metab., 10.1111/dom.14659 https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html. n.d. Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ, 339, 10.1136/bmj.b2700 Luchini, 2017, Assessing the quality of studies in meta-analyses: Advantages and limitations of the Newcastle Ottawa Scale, World J. Meta-Anal., 5, 80, 10.13105/wjma.v5.i4.80 The OpenSAFELY Collaborative, 2021, Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform, Epidemiology Hernán, 2010, The hazards of hazard ratios, Epidemiology, 21, 13, 10.1097/EDE.0b013e3181c1ea43 Wander, 2022, The incidence of diabetes among 2,777,768 veterans with and without recent SARS-CoV-2 infection, Diabetes Care, 45, 782, 10.2337/dc21-1686 Ruiz, 2018, Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study, Diabetologia, 61, 1996, 10.1007/s00125-018-4662-7 Krammer, 2018, Influenza, Nat. Rev. Dis. Prim., 4, 3, 10.1038/s41572-018-0002-y Pal, 2022, Endocrine follow-up during post-acute COVID-19: practical recommendations based on available clinical evidence, Endocr. Pr., 10.1016/j.eprac.2022.02.003 Salmi, 2022, New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic, Arch. Dis. Child, 107, 180, 10.1136/archdischild-2020-321220 Messaaoui, 2021, Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium, J. Pedia Endocrinol. Metab., 34, 1319, 10.1515/jpem-2021-0289 van der Heide, 2022, Limited extent and consequences of pancreatic SARS-CoV-2 infection, Cell Rep., 38, 10.1016/j.celrep.2022.110508 Montefusco, 2021, Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection, Nat. Metab., 3, 774, 10.1038/s42255-021-00407-6 Pal, 2020, COVID-19 and the endocrine system: exploring the unexplored, J. Endocrinol. Investig, 43, 1027, 10.1007/s40618-020-01276-8